 Anti-Dyskinesia Agents
"Anti-Dyskinesia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
| Descriptor ID |
D018726
|
| MeSH Number(s) |
D27.505.954.427.090
|
| Concept/Terms |
Anti-Dyskinesia Agents- Anti-Dyskinesia Agents
- Agents, Anti-Dyskinesia
- Anti Dyskinesia Agents
- Movement Disorder Agents
- Agents, Movement Disorder
- Disorder Agents, Movement
|
Below are MeSH descriptors whose meaning is more general than "Anti-Dyskinesia Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Dyskinesia Agents".
This graph shows the total number of publications written about "Anti-Dyskinesia Agents" by people in this website by year, and whether "Anti-Dyskinesia Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Dyskinesia Agents" by people in Profiles.
-
Gracies JM, Bayle N, Goldberg S, Simpson DM. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study. Arch Phys Med Rehabil. 2014 Jul; 95(7):1303-11.
-
Apkon SD, Cassidy D. Safety considerations in the use of botulinum toxins in children with cerebral palsy. PM R. 2010 Apr; 2(4):282-4.
-
Matthews DJ, Balaban B. [Management of spasticity in children with cerebral palsy]. Acta Orthop Traumatol Turc. 2009 Mar-Apr; 43(2):81-6.
-
Berman B, Seeberger L, Kumar R. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia. Mov Disord. 2005 Feb; 20(2):233-7.
-
Delgado MR, Wilson H, Johnston C, Richards S, Karol L. A preliminary report of the use of botulinum toxin type A in infants with clubfoot: four case studies. J Pediatr Orthop. 2000 Jul-Aug; 20(4):533-8.
-
Simpson DM. Treatment of spasticity with botulinum toxin. Muscle Nerve. 2000 Apr; 23(4):447-9.
-
Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sj?gren's syndrome: a preliminary report. J Rheumatol. 1997 Sep; 24(9):1842-3.
-
Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl. 1997; 6:S169-75.
-
Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996 May; 46(5):1306-10.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|